Therapeutic advances in spinal muscular atrophy: a review of clinical, safety, and economic considerations.

Belančić A, Maria Gkrinia EM, Lam YW, Vitezić D

Open source

DOI
10.3389/fphar.2026.1793581
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1793581,
  title = {Therapeutic advances in spinal muscular atrophy: a review of clinical, safety, and economic considerations.},
  author = {Belančić A and Maria Gkrinia EM and Lam YW and Vitezić D},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1793581},
  url = {https://doi.org/10.3389/fphar.2026.1793581}
}

RIS

TY  - JOUR
TI  - Therapeutic advances in spinal muscular atrophy: a review of clinical, safety, and economic considerations.
AU  - Belančić A
AU  - Maria Gkrinia EM
AU  - Lam YW
AU  - Vitezić D
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1793581
UR  - https://doi.org/10.3389/fphar.2026.1793581
ER  - 

APA

A, B., EM, M. G., YW, L., & D, V. (2026). Therapeutic advances in spinal muscular atrophy: a review of clinical, safety, and economic considerations.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1793581

Source records